Related Experiment Video
Updated: Aug 21, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Strategic use of antibiotics in the neonatal intensive care unit
1Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, 75 DeKalb Ave, Brooklyn, NY 11201, USA. catherine.tom@liu.edu
Insights
Neonatal infections are a major cause of infant death. Monitoring pathogen shifts and judicious antibiotic use are crucial for combating antibiotic resistance in neonatal intensive care units.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pharmacology
Background:
- Infections are a leading cause of morbidity and mortality in neonatal intensive care units (NICUs).
- Therapeutic interventions like mechanical ventilation can compromise natural infection barriers.
- Maternal and neonatal risk factors are known for early- and late-onset sepsis.
Purpose of the Study:
- To address the challenges of increasing antibiotic resistance and shifting pathogen prevalence in NICUs.
- To emphasize the need for strategic antibiotic use in neonatal populations.
- To highlight the importance of developing protocols for infection control and antibiotic stewardship.
Main Methods:
- Identification of common pathogens and their antibiotic resistance patterns.
- Monitoring of pathogen shifts within individual NICUs.
- Analysis of antibiotic characteristics for effective treatment selection.
Main Results:
- Common pathogens in NICUs often exhibit resistance to traditional antibiotics.
- Pathogen predominance can shift, necessitating changes in empiric antibiotic regimens.
- Continuous monitoring and strategic antibiotic selection are vital for patient care.
Conclusions:
- Modification of traditional antibiotic regimens may be required due to evolving resistance and pathogen shifts.
- Implementing infection control measures and judicious antibiotic use guidelines is essential.
- Developing specific protocols can minimize the threat of antibiotic resistance in NICUs.
Abstract:
Infection is one of the most common causes of infant morbidity and mortality in the neonatal intensive care unit, despite the availability of various therapeutic medical interventions, such as mechanical ventilation, that allow premature infants a better chance of survival. In fact, many of these therapeutic interventions violate the natural protective barriers for infection. Fortunately, maternal and neonatal risk factors have been identified for early- and late-onset sepsis and the prevalence of highly suspected pathogens for each type of infection influences the empiric selection of antibiotics. In many institutions, the common pathogens have developed resistance to antibiotics. In others, the predominance of pathogens has shifted. Both challenges may warrant modification of traditional antibiotic regimens. Continual monitoring of pathogen shifts within an individual neonatal intensive care unit and application of various antibiotic characteristics are key elements of strategic, safe, and effective use of antibiotics in this patient population. Development of a protocol incorporating infection control measures and guidelines for judicious use of antibiotics can minimize the threat of antibiotic resistance.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Microbiota Modulation by Antibiotics
Mechanism of Antibiotic Resistance in MRSA
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
